Viewing Study NCT03426202


Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2026-07-23 @ 9:54 PM
Study NCT ID: NCT03426202
Status: UNKNOWN
Last Update Posted: 2019-06-17
First Post: 2018-02-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effect of Modafinil on Affective and Cognitive Processing
Sponsor: University of Electronic Science and Technology of China
Organization:

Study Overview

Official Title: The Effect of Modafinil on Neural Processing During the Interference and Feedback Based Learning Task
Status: UNKNOWN
Status Verified Date: 2019-06
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study aims to examine whether a single dose of modafinil (200mg, p.o.) can affect feedback-based learning and interference processing in healthy male subjects.
Detailed Description: Based on previous animal and human research suggesting a catecholamine-mediated, potentially pro-cognitive, mechanism of action of modafinil, the present study seeks to explore effects of modafinil on feedback-based learning and interference processing in healthy subjects. To this end, the present randomized double-blind, between-subject, placebo-controlled pharmaco-fMRI experiment plans to determine the behavioral and neural effects of a single dose of p.o.modafinil (200mg) versus placebo on validated feedback-based learning and emotional/non-emotional cognitive conflict paradigms. To control for potential effects of pre-medication personality traits as well as effects of modafinil on subjective task performance, subjects will be administered pre-treatment assessing relevant personality traits and post-treatment assessments of meta-cognitive confidence estimation.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: